Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026)
Quanterix's (QTRX) quarterly Asset Writedowns and Impairment came in at $305000.0 in Q1 2026, up 475.47% YoY from $53000.0 in Q1 2025, and down 36.85% on a QoQ basis from $483000.0 in Q4 2025.
Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
Quanterix (QTRX) has 6 years of Asset Writedowns and Impairment data on file, last reported at $305000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 475.47% year-over-year to $305000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 6965.0% YoY) and the FY2025 annual result came in at $7.8 million, changed N/A from the prior year.
- Asset Writedowns and Impairment eased to $305000.0 in Q1 2026, from $483000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $25.7 million in Q4 2022 to a low of -$676000.0 in Q3 2024.
- A 5-year average of $2.3 million and a median of $241500.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment surged 35304.11% — and 2024, when it sank 989.47%.
- Tracing QTRX's Asset Writedowns and Impairment over 5 years: stood at $25.7 million in 2022, then tumbled by 95.21% to $1.2 million in 2023, then tumbled by 154.91% to -$676000.0 in 2024, then jumped by 171.45% to $483000.0 in 2025, then tumbled by 36.85% to $305000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $305000.0 (Q1 2026), $483000.0 (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.93 Mn |
| Jun 30, 2026 | 26.93 Mn |
| Mar 31, 2026 | 305,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Sep 30, 2024 | -676,000.00 |
| Sep 30, 2024 | -676,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |